| A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike M Claireaux, TG Caniels, M de Gast, J Han, D Guerra, G Kerster, ... Nature communications 13 (1), 4539, 2022 | 49 | 2022 |
| Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate K Sliepen, L Radić, J Capella-Pujol, Y Watanabe, I Zon, A Chumbe, ... Nature communications 13 (1), 7271, 2022 | 30 | 2022 |
| Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins MD Kalemera, J Capella-Pujol, A Chumbe, A Underwood, RA Bull, ... Journal of General Virology 102 (1), 001512, 2021 | 29 | 2021 |
| Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions TG Caniels, M Medina-Ramírez, J Zhang, A Sarkar, S Kumar, ... Cell Reports Medicine 4 (4), 2023 | 24 | 2023 |
| Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses L Radić, K Sliepen, V Yin, M Brinkkemper, J Capella-Pujol, AI Schriek, ... Iscience 26 (4), 2023 | 7 | 2023 |
| Signatures of VH1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins J Capella-Pujol, M de Gast, L Radić, I Zon, A Chumbe, S Koekkoek, ... Nature communications 14 (1), 4036, 2023 | 6 | 2023 |
| A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns A Chumbe, M Grobben, J Capella-Pujol, SM Koekkoek, I Zon, S Slamanig, ... Virus Research 341, 199308, 2024 | 3 | 2024 |
| Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein L Radić, A Offersgaard, T Kadavà, I Zon, J Capella-Pujol, F Mulder, ... bioRxiv, 2024.10. 04.616615, 2024 | | 2024 |
| HIV-1 Germline-Targeting Vaccine Regimen Selects for Rare Immunoglobulin Insertions and Deletions Typical of VRC01-Class Antibodies TG Caniels, M Medina-Ramírez, J Zhang, A Sarkar, S Kumar, ... | | |
